The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Genetic prognostic and predictive markers in colorectal cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,728
Frosst, P., Blom, H. J., Milos, R., Goyette, P., Sheppard, C. A., Matthews, R. G., Boers, G. J. H., den Heijer, M., Kluijtmans, L. A. J., van den Heuve, L. P., et al. (1995) · Nature Genetics · doi:10.1038/ng0595-111 · Cited by 5,653
Cunningham, D., Humblet, Y., Siena, S., Khayat, D., Bleiberg, H., Santoro, A., Bets, D., Mueser, M., Harstrick, A., Verslype, C., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033025 · Cited by 5,035
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
Van Cutsem, E., Köhne, C.-H., Hitre, E., Zaluski, J., Chang Chien, C.-R., Makhson, A., D'Haens, G., Pintér, T., Lim, R., Bodoky, G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805019 · Cited by 3,877
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
Karapetis, C. S., Khambata-Ford, S., Jonker, D. J., O'Callaghan, C. J., Tu, D., Tebbutt, N. C., Simes, R. J., Chalchal, H., Shapiro, J. D., Robitaille, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804385 · Cited by 3,622
Targeting RAS signalling pathways in cancer therapy
Downward, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc969 · Cited by 3,256
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
Amado, R. G., Wolf, M., Peeters, M., Van Cutsem, E., Siena, S., Freeman, D. J., Juan, T., Sikorski, R., Suggs, S., Radinsky, R., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.7116 · Cited by 3,207
Epidermal growth factor-related peptides and their receptors in human malignancies
Salomon, D. S., Brandt, R., Ciardiello, F., & Normanno, N. (1995) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(94)00144-i · Cited by 2,690
Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., et al. (2007) · Science · doi:10.1126/science.1142364 · Cited by 2,194
Ribic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160
Weisenberger, D. J., Siegmund, K. D., Campan, M., Young, J., Long, T. I., Faasse, M. A., Kang, G. H., Widschwendter, M., Weener, D., Buchanan, D., et al. (2006) · Nature Genetics · doi:10.1038/ng1834 · Cited by 1,990
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
Herman, J. G., Umar, A., Polyak, K., Graff, J. R., Ahuja, N., Issa, J.-P. J., Markowitz, S., Willson, J. K. V., Hamilton, S. R., Kinzler, K. W., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6870 · Cited by 1,887
Systematic Review of Microsatellite Instability and Colorectal Cancer Prognosis
Popat, S., Hubner, R., & Houlston, R. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.086 · Cited by 1,830
A Common Variant on Chromosome 9p21 Affects the Risk of Myocardial Infarction
Helgadottir, A., Thorleifsson, G., Manolescu, A., Gretarsdottir, S., Blondal, T., Jonasdottir, A., Jonasdottir, A., Sigurdsson, A., Baker, A., Palsson, A., et al. (2007) · Science · doi:10.1126/science.1142842 · Cited by 1,594
ASCO 2006 Update of Recommendations for the Use of Tumor Markers in Gastrointestinal Cancer
Locker, G. Y., Hamilton, S., Harris, J., Jessup, J. M., Kemeny, N., Macdonald, J. S., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2644 · Cited by 1,592
Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
Di Nicolantonio, F., Martini, M., Molinari, F., Sartore-Bianchi, A., Arena, S., Saletti, P., De Dosso, S., Mazzucchelli, L., Frattini, M., Siena, S., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.0786 · Cited by 1,591
Schetter, A. J., Leung, S. Y., Sohn, J. J., Zanetti, K. A., Bowman, E. D., Yanaihara, N., Yuen, S. T., Chan, T. L., Kwong, D. L. W., Au, G. K. H., et al. (2008) · JAMA · doi:10.1001/jama.299.4.425 · Cited by 1,578
The classification of cancer of the rectum
Dukes, C. E. (1932) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700350303 · Cited by 1,505
Hunter, D. J., Kraft, P., Jacobs, K. B., Cox, D. G., Yeager, M., Hankinson, S. E., Wacholder, S., Wang, Z., Welch, R., Hutchinson, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2075 · Cited by 1,481
Eberhard, D. A., Johnson, B. E., Amler, L. C., Goddard, A. D., Heldens, S. L., Herbst, R. S., Ince, W. L., Jänne, P. A., Januario, T., Johnson, D. H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.857 · Cited by 1,461
Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study
QUASAR Collaborative Group (2007) · The Lancet · doi:10.1016/s0140-6736(07)61866-2 · Cited by 1,437
Rampino, N., Yamamoto, H., Ionov, Y., Li, Y., Sawai, H., Reed, J. C., & Perucho, M. (1997) · Science · doi:10.1126/science.275.5302.967 · Cited by 1,326
Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/386761a0 · Cited by 1,240
Prognostic Factors in Prostate Cancer: College of American Pathologists Consensus Statement 1999
Bostwick, D. G., Grignon, D. J., Hammond, M. E. H., Amin, M. B., Cohen, M., Crawford, D., Gospadarowicz, M., Kaplan, R. S., Miller, D. S., Montironi, R., et al. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0995-pfipc · Cited by 1,239
Prognostic Factors in Colorectal Cancer: College of American Pathologists Consensus Statement 1999
Compton, C. C., Fielding, L. P., Burgart, L. J., Conley, B., Cooper, H. S., Hamilton, S. R., Hammond, M. E. H., Henson, D. E., Hutter, R. V. P., Nagle, R. B., et al. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0979-pficc · Cited by 1,230
RAF/RAS oncogenes and mismatch-repair status
Rajagopalan, H., Bardelli, A., Lengauer, C., Kinzler, K. W., Vogelstein, B., & Velculescu, V. E. (2002) · Nature · doi:10.1038/418934a · Cited by 1,224 · cited 1×
“BRAF acts downstream from KRAS , and mutations in the two genes seem to be mutually exclusiv”
BackgroundCarter, S. L., Eklund, A. C., Kohane, I. S., Harris, L. N., & Szallasi, Z. (2006) · Nature Genetics · doi:10.1038/ng1861 · Cited by 1,193
Roth, A. D., Tejpar, S., Delorenzi, M., Yan, P., Fiocca, R., Klingbiel, D., Dietrich, D., Biesmans, B., Bodoky, G., Barone, C., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.3452 · Cited by 1,158
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24
Yeager, M., Orr, N., Hayes, R. B., Jacobs, K. B., Kraft, P., Wacholder, S., Minichiello, M. J., Fearnhead, P., Yu, K., Chatterjee, N., et al. (2007) · Nature Genetics · doi:10.1038/ng2022 · Cited by 1,122
Chung, K. Y., Shia, J., Kemeny, N. E., Shah, M., Schwartz, G. K., Tse, A., Hamilton, A., Pan, D., Schrag, D., Schwartz, L., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.037 · Cited by 1,081
Prediction of cancer outcome with microarrays: a multiple random validation strategy
Michiels, S., Koscielny, S., & Hill, C. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17866-0 · Cited by 1,025
Pitfalls in the Use of DNA Microarray Data for Diagnostic and Prognostic Classification
Simon, R., Radmacher, M. D., Dobbin, K., & McShane, L. M. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.1.14 · Cited by 1,006
Genomic and Epigenetic Instability in Colorectal Cancer Pathogenesis
Grady, W. M., & Carethers, J. M. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.076 · Cited by 960
The Catalogue of Somatic Mutations in Cancer (COSMIC)
Forbes, S. A., Bhamra, G., Bamford, S., Dawson, E., Kok, C., Clements, J., Menzies, A., Teague, J. W., Futreal, P. A., & Stratton, M. R. (2008) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg1011s57 · Cited by 904
Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ study
Andreyev, H. J. N., Norman, A. R., Cunningham, D., Oates, J., Dix, B. R., Iacopetta, B. J., Young, J., Walsh, T., Ward, R., Hawkins, N., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1964 · Cited by 872
Ogino, S., Nosho, K., Kirkner, G. J., Kawasaki, T., Meyerhardt, J. A., Loda, M., Giovannucci, E. L., & Fuchs, C. S. (2009) · Gut · doi:10.1136/gut.2008.155473 · Cited by 777
Kirsten ras mutations in patients with colorectal cancer: The multicenter “RASCAL” study
Andreyev, H. J. N., Norman, A. R., Clarke, P. A., Cunningham, D., & Oates, J. R. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.9.675 · Cited by 748
Parsons, R. E., Myeroff, L. L., Liu, B., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., & Vogelstein, B. (1995) · PubMed · Cited by 738
Poor Survival Associated with the BRAF V600E Mutation in Microsatellite-Stable Colon Cancers
Samowitz, W. S., Sweeney, C., Herrick, J., Albertsen, H., Levin, T. R., Murtaugh, M. A., Wolff, R. K., & Slattery, M. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0404 · Cited by 737
UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity
Iyer, L., Das, S., Janisch, L., Wen, M., Ramírez, J., Karrison, T., Fleming, G. F., Vokes, E. E., Schilsky, R. L., & Ratain, M. J. (2002) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500072 · Cited by 720
Thousands of samples are needed to generate a robust gene list for predicting outcome in cancer
Ein-Dor, L., Zuk, O., & Domany, E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601231103 · Cited by 689
Dupuy, A., & Simon, R. M. (2007) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djk018 · Cited by 632
Colorectal cancer and genetic alterations in the Wnt pathway
Segditsas, S., & Tomlinson, I. (2006) · Oncogene · doi:10.1038/sj.onc.1210059 · Cited by 591
Self-citationSamowitz, W. S., Albertsen, H., Herrick, J., Levin, T. R., Sweeney, C., Murtaugh, M. A., Wolff, R. K., & Slattery, M. L. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.06.020 · Cited by 577
The CORGI Consortium, Tomlinson, I. P., The EPICOLON Consortium, Webb, E., Carvajal-Carmona, L., Broderick, P., Howarth, K., Pittman, A. M., Spain, S., Lubbe, S., et al. (2008) · Nature Genetics · doi:10.1038/ng.111 · Cited by 562
Self-citationIntegrated genetic and epigenetic analysis identifies three different subclasses of colon cancer
Shen, L., Toyota, M., Kondo, Y., Lin, E., Zhang, L., Guo, Y., Hernandez, N. S., Chen, X., Ahmed, S., Konishi, K., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704652104 · Cited by 559
Inactivation of hCDC4 can cause chromosomal instability
Rajagopalan, H., Jallepalli, P. V., Rago, C., Velculescu, V. E., Kinzler, K. W., Vogelstein, B., & Lengauer, C. (2004) · Nature · doi:10.1038/nature02313 · Cited by 551
Glutathione S-transferase polymorphisms: cancer incidence and therapy
McIlwain, C. C., Townsend, D. M., & Tew, K. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209373 · Cited by 523
Systemic Treatment of Colorectal Cancer
Wolpin, B. M., & Mayer, R. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.098 · Cited by 504
Diagnostic and Prognostic MicroRNAs in Stage II Colon Cancer
Schepeler, T., Reinert, J. T., Ostenfeld, M. S., Christensen, L. L., Silahtaroglu, A. N., Dyrskjøt, L., Wiuf, C., Sørensen, F. J., Kruhøffer, M., Laurberg, S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6110 · Cited by 492
Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil
van Kuilenburg, A. B. P. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.12.004 · Cited by 488
Bias as a threat to the validity of cancer molecular-marker research
Ransohoff, D. F. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1550 · Cited by 487
UGT1A1*28 Genotype and Irinotecan-Induced Neutropenia: Dose Matters
Hoskins, J. M., Goldberg, R. M., Qu, P., Ibrahim, J. G., & McLeod, H. L. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm115 · Cited by 469
Preoperative Carcinoembryonic Antigen Level as a Prognostic Indicator in Colorectal Cancer
Wanebo, H. J., Rao, B., Pinsky, C. M., Hoffman, R. G., Stearns, M., Schwartz, M. K., & Oettgen, H. F. (1978) · New England Journal of Medicine · doi:10.1056/nejm197808312990904 · Cited by 468
Gene Expression Profiles and Molecular Markers To Predict Recurrence of Dukes' B Colon Cancer
Wang, Y., Jatkoe, T., Zhang, Y., Mutch, M. G., Talantov, D., Jiang, J., McLeod, H. L., & Atkins, D. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.186 · Cited by 460
False discovery rate, sensitivity and sample size for microarray studies
Pawitan, Y., Michiels, S., Koscielny, S., Gusnanto, A., & Ploner, A. (2005) · Bioinformatics · doi:10.1093/bioinformatics/bti448 · Cited by 455
Metabolism and mechanism of action of 5-fluorouracil
Parker, W. B., & Cheng, Y. C. (1990) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(90)90056-8 · Cited by 451
Saltz, L. B., Niedzwiecki, D., Hollis, D., Goldberg, R. M., Hantel, A., Thomas, J. P., Fields, A. L. A., & Mayer, R. J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.2144 · Cited by 449
Popat, S., Matakidou, A., & Houlston, R. S. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.064 · Cited by 449
Souza, R. F., Appel, R., Yin, J., Wang, S., Smolinski, K. N., Abraham, J. M., Zou, T.-T., Shi, Y.-Q., Lei, J., Cottrell, J., et al. (1996) · Nature Genetics · doi:10.1038/ng1196-255 · Cited by 445
Russo, A., Bazan, V., Iacopetta, B., Kerr, D., Soussi, T., & Gebbia, N. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.471 · Cited by 416
Self-citationFbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene
Mao, J.-H., Perez-losada, J., Wu, D., DelRosario, R., Tsunematsu, R., Nakayama, K. I., Brown, K., Bryson, S., & Balmain, A. (2004) · Nature · doi:10.1038/nature03155 · Cited by 390
Swanton, C., Marani, M., Pardo, O., Warne, P. H., Kelly, G., Sahai, E., Elustondo, F., Chang, J., Temple, J., Ahmed, A. A., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.04.011 · Cited by 381
Self-citationMicrosatellite Instability and 8p Allelic Imbalance in Stage B2 and C Colorectal Cancers
Halling, K. C., French, A. J., McDonnell, S. K., Burgart, L. J., Schaid, D. J., Peterson, B. J., Moon-Tasson, L., Mahoney, M. R., Sargent, D. J., O'Connell, M. J., et al. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.15.1295 · Cited by 375
Van Cutsem, E., Lang, I., D'haens, G., Moiseyenko, V., Zaluski, J., Folprecht, G., Tejpar, S., Kisker, O., Stroh, C., & Rougier, P. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.2 · Cited by 372
Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis
Walther, A., Houlston, R., & Tomlinson, I. (2008) · Gut · doi:10.1136/gut.2007.135004 · Cited by 368
Self-citationStoehlmacher, J., Park, D. J., Zhang, W., Yang, D., Groshen, S., Zahedy, S., & Lenz, H.-J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601975 · Cited by 364
Bertagnolli, M. M., Niedzwiecki, D., Compton, C. C., Hahn, H. P., Hall, M., Damas, B., Jewell, S. D., Mayer, R. J., Goldberg, R. M., Saltz, L. B., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.2071 · Cited by 364
Mandola, M. V., Stoehlmacher, J., Muller‐Weeks, S., Cesarone, G., Yu, M. C., Lenz, H., & Ladner, R. D. (2003) · PubMed · Cited by 362
Molecular basis of the human dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity.
Wei, X., McLeod, H. L., McMurrough, J., Gonzalez, F. J., & Fernandez-Salguero, P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118830 · Cited by 356
IYER, L., HALL, D., DAS, S., MORTELL, M., RAMIREZ, J., KIM, S., DIRIENZO, A., & RATAIN, M. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70078-0 · Cited by 356
Samowitz, W. S., Curtin, K., Schaffer, D., Robertson, M. A., Leppert, M., & Slattery, M. L. (2000) · PubMed · Cited by 351
Kim, G. P., Colangelo, L. H., Wieand, H. S., Paik, S., Kirsch, I. R., Wolmark, N., & Allegra, C. J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.8172 · Cited by 342
Rodriguez, J., Frigola, J., Vendrell, E., Risques, R.-A., Fraga, M. F., Morales, C., Moreno, V., Esteller, M., Capellà, G., Ribas, M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0293 · Cited by 335
Malkhosyan, S., Rampino, N., Yamamoto, H., & Perucho, M. (1996) · Nature · doi:10.1038/382499a0 · Cited by 327
Predictive ability of DNA microarrays for cancer outcomes and correlates: an empirical assessment
Ntzani, E. E., & Ioannidis, J. P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14686-7 · Cited by 323
Association of k-ras, b-raf, and p53 Status With the Treatment Effect of Bevacizumab
Ince, W. L., Jubb, A. M., Holden, S. N., Holmgren, E. B., Tobin, P., Sridhar, M., Hurwitz, H. I., Kabbinavar, F., Novotny, W. F., Hillan, K. J., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji174 · Cited by 319
members of the CORGI Consortium, Jaeger, E., Webb, E., Howarth, K., Carvajal-Carmona, L., Rowan, A., Broderick, P., Walther, A., Spain, S., Pittman, A., et al. (2008) · Nature Genetics · doi:10.1038/ng.2007.41 · Cited by 304
Self-citationMandola, M. V., Stoehlmacher, J., Zhang, W., Groshen, S., Yu, M. C., Iqbal, S., Lenz, H.-J., & Ladner, R. D. (2004) · Pharmacogenetics · doi:10.1097/00008571-200405000-00007 · Cited by 298
Ogino, S., Kawasaki, T., Kirkner, G. J., Loda, M., & Fuchs, C. S. (2006) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2006.060082 · Cited by 294
P53 abnormalities and outcomes in colorectal cancer: a systematic review
Munro, A. J., Lain, S., & Lane, D. P. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602358 · Cited by 289
Microarrays and molecular research: noise discovery?
Ioannidis, J. P. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17878-7 · Cited by 287
Hypermethylator Phenotype in Sporadic Colon Cancer: Study on a Population-Based Series of 582 Cases
Barault, L., Charon-Barra, C., Jooste, V., de la Vega, M. F., Martin, L., Roignot, P., Rat, P., Bouvier, A.-M., Laurent-Puig, P., Faivre, J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1171 · Cited by 286
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer
Lanza, G., Ferracin, M., Gafà, R., Veronese, A., Spizzo, R., Pichiorri, F., Liu, C.-G., Calin, G. A., Croce, C. M., & Negrini, M. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-54 · Cited by 285
Palliative Thoracic Radiotherapy for Lung Cancer: A Systematic Review
Fairchild, A., Harris, K., Barnes, E., Wong, R., Lutz, S., Bezjak, A., Cheung, P., & Chow, E. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.3312 · Cited by 270
Dependence of Paclitaxel Sensitivity on a Functional Spindle Assembly Checkpoint
Sudo, T., Nitta, M., Saya, H., & Ueno, N. T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2013 · Cited by 262
Alternative genetic pathways in colorectal carcinogenesis
Olschwang, S., Hamelin, R., Laurent-Puig, P., Thuille, B., De Rycke, Y., Li, Y.-J., Muzeau, F., Girodet, J., Salmon, R.-J., & Thomas, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.12122 · Cited by 251
Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis
Yamada, Y., Jackson-Grusby, L., Linhart, H., Meissner, A., Eden, A., Lin, H., & Jaenisch, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506612102 · Cited by 245
Jass, J. R., Biden, K. G., Cummings, M. C., Simms, L. A., Walsh, M., Schoch, E., Meltzer, S. J., Wright, C., Searle, J., Young, J., et al. (1999) · Journal of Clinical Pathology · doi:10.1136/jcp.52.6.455 · Cited by 241
Bokemeyer, C., Bondarenko, I., Hartmann, J. T., De Braud, F. G., Volovat, C., Nippgen, J., Stroh, C., Celik, I., & Koralewski, P. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.4000 · Cited by 240
Fallik, D., Borrini, F., Boige, V., Viguier, J., Jacob, S., Miquel, C., Sabourin, J., Ducreux, M. P., & Praz, F. (2003) · PubMed · Cited by 232
Prognostic Impact of Microsatellite Instability and DNA Ploidy in Human Colon Carcinoma Patients
Sinicrope, F. A., Rego, R. L., Halling, K. C., Foster, N., Sargent, D. J., La Plant, B., French, A. J., Laurie, J. A., Goldberg, R. M., Thibodeau, S. N., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.06.005 · Cited by 230
Kawakami, K., Salonga, D. S., Park, J. M., et al. (2001) · PubMed · Cited by 227
Prognostic indicators of colon tumors. The gastrointestinal tumor study group experience
Steinberg, S. M., Barkin, J. S., Kaplan, R. S., & Stablein, D. M. (1986) · Cancer · doi:10.1002/1097-0142(19860501)57:9<1866::aid-cncr2820570928>3.0.co;2-t · Cited by 221
Stage II Colon Cancer Prognosis Prediction by Tumor Gene Expression Profiling
Barrier, A., Boelle, P.-Y., Roser, F., Gregg, J., Tse, C., Brault, D., Lacaine, F., Houry, S., Huguier, M., Franc, B., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.0229 · Cited by 214
Lecomte, T., Landi, B., Beaune, P., Laurent-Puig, P., & Loriot, M.-A. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2076 · Cited by 211
Del Rio, M., Molina, F., Bascoul-Mollevi, C., Copois, V., Bibeau, F., Chalbos, P., Bareil, C., Kramar, A., Salvetat, N., Fraslon, C., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.4187 · Cited by 210
Polymorphism in the thymidylate synthase promoter enhancer region in colorectal cancer
Marsh, S., McKay, J., Cassidy, J., & McLeod, H. (2001) · International Journal of Oncology · doi:10.3892/ijo.19.2.383 · Cited by 205
SMAD4 as a Prognostic Marker in Colorectal Cancer
Alazzouzi, H., Alhopuro, P., Salovaara, R., Sammalkorpi, H., Järvinen, H., Mecklin, J.-P., Hemminki, A., Schwartz, S., Aaltonen, L. A., & Arango, D. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1458 · Cited by 202
Jakobsen, A., Nielsen, J. N., Gyldenkerne, N., & Lindeberg, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.219 · Cited by 191
Popat, S., & Houlston, R. S. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.04.039 · Cited by 187
Cohen, V., Panet-Raymond, V., Sabbaghian, N., Morin, I., Batist, G., & Rozen, R. R. (2003) · PubMed · Cited by 183
Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy
KWEEKEL, D., GELDERBLOM, H., & GUCHELAAR, H. (2005) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2004.12.006 · Cited by 179
Randomised trials of HIV prevention
Gray, R. H., & Wawer, M. J. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61058-7 · Cited by 153
Thorstensen, L., Lind, G. E., Løvig, T., Diep, C. B., Meling, G. I., Rognum, T. O., & Lothe, R. A. (2005) · Neoplasia · doi:10.1593/neo.04448 · Cited by 148
Prognostic factors in advanced colorectal carcinoma
Kemeny, N. E., & Braun, D. W. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)91066-5 · Cited by 145
Gene-Expression Profiling Predicts Recurrence in Dukes’ C Colorectal Cancer
Arango, D., Laiho, P., Kokko, A., Alhopuro, P., Sammalkorpi, H., Salovaara, R., Nicorici, D., Hautaniemi, S., Alazzouzi, H., Mecklin, J., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.06.066 · Cited by 137
Étienne-Grimaldi, M.-C., Formento, J., Chazal, M., Francoual, M., Magn�, N., Formento, P., Bourgeon, A., Seitz, J.-F., Delpéro, J., Létoublon, C., et al. (2004) · Pharmacogenetics · doi:10.1097/00008571-200412000-00001 · Cited by 134
Genomic instability occurs in colorectal carcinomas but not in adenomas
Young, J. P., Leggett, B., Gustafson, C. E., Ward, M., Searle, J. W., Thomas, L., Buttenshaw, R. L., & Chenevix‐Trench, G. (1993) · Human Mutation · doi:10.1002/humu.1380020505 · Cited by 131
Lin, Y.-H., Friederichs, J., Black, M. A., Mages, J., Rosenberg, R., Guilford, P., Phillips, V., Thompson-Fawcett, M. W., Kasabov, N. K., Toro, T. T., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2734 · Cited by 131
Prognostic significance of allelic loss at chromosome 18q21 for stage II colorectal cancer
Carethers, J. M., Hawn, M. T., Greenson, J. K., Hitchcock, C. L., & Boland, C. R. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70424-x · Cited by 131
Network Analysis of Oncogenic Ras Activation in Cancer
Stites, E. C., Trampont, P. C., Ma, Z., & Ravichandran, K. S. (2007) · Science · doi:10.1126/science.1144642 · Cited by 125
Matsuzaki, K., Deng, G., Tanaka, H., Kakar, S., Miura, S., & Kim, Y. S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0859 · Cited by 123
Liang, J., Huang, K., Lai, H., Lee, P., Cheng, Y., Hsu, H., Cheng, A., Hsu, C., Yeh, K., Wang, S., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10643 · Cited by 120
Grade, M., Hörmann, P., Becker, S., Hummon, A. B., Wangsa, D., Varma, S., Simon, R., Liersch, T., Heinz Becker, A., Difilippantonio, M. J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1514 · Cited by 120
Cadherin–catenin expression in primary colorectal cancer: a survival analysis
Hugh, T. J., Dillon, S. A., Taylor, B. A., Pignatelli, M., Poston, G. J., & Kinsella, A. R. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690461 · Cited by 114
Liu, C., Chen, P., Chiou, T.-J., et al. (2008) · Cancer · doi:10.1002/cncr.23370 · Cited by 114
Cheng, Y., Pinças, H., Bacolod, M. D., Schemmann, G. S., Giardina, S. F., Huang, J., Barral, S., Idrees, K., Khan, S. A., Zeng, Z., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0216 · Cited by 108
Sharma, R., Hoskins, J. M., Rivory, L. P., Zucknick, M., London, R., Liddle, C., & Clarke, S. J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0425 · Cited by 107
Colon cancer prognosis prediction by gene expression profiling
Barrier, A. J., Lemoine, A., Boëlle, P., Tsé, C., Brault, D., Chiappini, F., Brettschneider, J. A., LACAINE, F., Houry, S., Huguier, M., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208984 · Cited by 105
SMAD4 Levels and Response to 5-Fluorouracil in Colorectal Cancer
Alhopuro, P., Alazzouzi, H., Sammalkorpi, H., Dávalos, V., Salovaara, R., Hemminki, A., Järvinen, H., Mecklin, J., Schwartz, S., Aaltonen, L. A., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0244 · Cited by 105
Classification of Dukes' B and C colorectal cancers using expression arrays
Frederiksen, C. M., Knudsen, S., Laurberg, S., & Ørntoft, T. F. (2003) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-003-0434-x · Cited by 95
Challenges in Projecting Clustering Results Across Gene Expression–Profiling Datasets
Lusa, L., McShane, L. M., Reid, J. F., Cecco, L. D., Ambrogi, F., Biganzoli, E. M., Gariboldi, M., & Pierotti, M. A. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm216 · Cited by 92
Tejpar, S., Peeters, M., Humblet, Y., Vermorken, J. B., Hertogh, G. D., Roock, W. D., Nippgen, J., von Heydebreck, A., Stroh, C., & Cutsem, E. V. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.4001 · Cited by 92
Vilar, E., Scaltriti, M., Balmañà, J., Saura, C., Guzmán, M., Arribas, J., Baselga, J. M., & Tabernero, J. M. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604691 · Cited by 91
Sargent, D. J., Marsoni, S., Thibodeau, S. N., Labianca, R., Hamilton, S. R., Torri, V., Monges, G., Ribic, C. M., Grothey, A. A., & Gallinger, S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.4008 · Cited by 91
Kemp, Z., Rowan, A., Chambers, W. M., Wortham, N. C., Halford, S. E. R., Sieber, O. M., Mortensen, N., Herbay, A. V., Gunther, T., Ilyas, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2565 · Cited by 90
Self-citationChemotherapeutic implications in microsatellite unstable colorectal cancer1
Jo, W., & Carethers, J. M. (2006) · Cancer Biomarkers · doi:10.3233/cbm-2006-21-206 · Cited by 87
Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses
Sahlberg, K. K., Lind, G. E., Diep, C. B., Meling, G. I., Brandal, L. T., Nesland, J. M., Myklebost, O., Rognum, T. O., Giercksky, K.-E., Skotheim, R. I., et al. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-2 · Cited by 84
The Role of Pharmacogenetics and Pharmacogenomics in Cancer Chemotherapy with 5-Fluorouracil
Diasio, R. B., & Johnson, M. R. (2000) · Pharmacology · doi:10.1159/000028401 · Cited by 82
Refining Molecular Analysis in the Pathways of Colorectal Carcinogenesis
Rowan, A., Halford, S. E. R., Gaasenbeek, M., Kemp, Z., Sieber, O. M., Volikos, E., Douglas, E. J., Fiegler, H., Carter, N. P., Talbot, I., et al. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00618-x · Cited by 79
Self-citationBoulay, J.-L., Mild, G., Lowy, A. J., Reuter, J., Lagrange, M., Terracciano, L., Laffer, U. T., Herrmann, R., & Rochlitz, C. F. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600511 · Cited by 79
Wang, C., van Rijnsoever, M., Grieu, F., Bydder, S. A., Elsaleh, H., Joseph, D. J., Harvey, J. M., & Iacopetta, B. J. (2003) · Oncology · doi:10.1159/000069311 · Cited by 73
Bondi, J., Bukholm, G., Nesland, J. M., et al. (2004) · Apmis · doi:10.1111/j.1600-0463.2004.apm1120109.x · Cited by 66
Prognosis of stage II colon cancer by non-neoplastic mucosa gene expression profiling
Barrier, A. J., Roser, F., Boëlle, P., Franc, B., Tsé, C., Brault, D., LACAINE, F., Houry, S., Callard, P., Penna, C., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1210060 · Cited by 63
Development of a Clinically Feasible Molecular Assay to Predict Recurrence of Stage II Colon Cancer
Jiang, Y., Casey, G., Lavery, I. C., Zhang, Y., Talantov, D., McGreevy, M., Skacel, M., Manilich, E. A., Mazumder, A., Atkins, D., et al. (2008) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2008.080011 · Cited by 62
Lurje, G., Zhang, W., Yang, D., Groshen, S. G., Hendifar, A. E., Husain, H., Nagashima, F., Chang, H. M., Fazzone, W., Ladner, R. D., et al. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282f4aea6 · Cited by 52
Barrier, A. J., Boëlle, P., Lemoine, A., Tsé, C., Brault, D., Chiappini, F., LACAINE, F., Houry, S., Huguier, M., Flahault, A., et al. (2005) · Diseases of the Colon & Rectum · doi:10.1007/s10350-005-0175-9 · Cited by 33
Evolution of nonsurgical therapy for colorectal cancer
Midgley, R. S., Yanagisawa, Y., & Kerr, R. S. (2009) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep1337 · Cited by 30
Self-citationLyman, G. H., & Kuderer, N. M. (2006) · Clinical Breast Cancer · doi:10.3816/cbc.2006.n.053 · Cited by 27
Pharmacogenomics in colorectal cancer
Lenz, H. J. (2003) · Seminars in Oncology · doi:10.1016/s0093-7754(03)00405-6 · Cited by 19
Cited by
Serine, glycine and one-carbon units: cancer metabolism in full circle
Locasale, J. W. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3557 · Cited by 1,673
Dependency of Colorectal Cancer on a TGF-β-Driven Program in Stromal Cells for Metastasis Initiation
Calon, A., Espinet, E., Palomo-Ponce, S., Tauriello, D. V. F., Iglesias, M., Céspedes, M. V., Sevillano, M., Nadal, C., Jung, P., Zhang, X. H.-F., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.013 · Cited by 1,060
Role of the Serrated Pathway in Colorectal Cancer Pathogenesis
Leggett, B., & Whitehall, V. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.066 · Cited by 977
Bertotti, A., Migliardi, G., Galimi, F., Sassi, F., Torti, D., Isella, C., Corà, D., Di Nicolantonio, F., Buscarino, M., Petti, C., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0109 · Cited by 939
Strategies and challenges for the next generation of therapeutic antibodies
Beck, A., Wurch, T., Bailly, C., & Corvaia, N. (2010) · Nature Reviews Immunology · doi:10.1038/nri2747 · Cited by 847
Metadata
- Authors
- Walther, A., Johnstone, E., Swanton, C., Midgley, R., Tomlinson, I., & Kerr, D.
- Venue
- Nature Reviews Cancer
- Published
- 2009-06-18
- Volume
- 9
- Issue
- 7
- Pages
- 489-499
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2085971602
- Cited by
- 705
- References
- 143
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.